SUN.L
Surgical Innovations Group plc
LSEGBpEQUITY
Healthcare
DELAYED
Last price
0.43
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.43
Day high
0.00
Day low
0.00
Volume
2.00M
Market cap
$3.96M
P/E (TTM)
—
52W range
0.00 – 0.74
Trailing performance
Returnvs SPY
1W
0.00%
+1.2%
1M
-15.00%
-18.3%
3M
-10.53%
-12.9%
6M
-5.56%
-17.4%
YTD
-5.56%
-17.5%
1Y
-39.29%
-59.4%
3Y
-76.39%
-151.4%
5Y
-84.82%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SUN.L open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
503.42M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 30, 26 | Getz Bros Co Ltd |
— | 0 | — | Direct |
| Jun 30, 26 | Hargreaves Lansdown Asset Management Ltd. |
— | 0 | — | Direct |
| Jun 30, 26 | John (C W N) |
— | 0 | — | Direct |
| Jun 30, 26 | Aberdeen Asset Management, Ltd. |
— | 0 | — | Direct |
| Jun 30, 26 | BGF Investment Management, Ltd. |
— | 0 | — | Direct |
| Jun 30, 26 | Dow (Gordon Lawrence Alan) |
— | 0 | — | Direct |
| Jun 30, 26 | Freeman (Linda Margaret) |
— | 0 | — | Direct |
| Jun 30, 26 | Thalassa Holdings Ltd |
— | 0 | — | Direct |
| Apr 20, 26 | Thalassa Holdings Ltd |
— | 0 | — | Direct |
| Apr 20, 26 | Hargreaves Lansdown Asset Management Ltd. |
— | 0 | — | Direct |
| Apr 20, 26 | John (C W N) |
— | 0 | — | Direct |
| Apr 20, 26 | Marsh (David John) |
— | 0 | — | Direct |
| Apr 20, 26 | BGF Investment Management, Ltd. |
— | 0 | — | Direct |
| Apr 20, 26 | Dow (Gordon Lawrence Alan) |
— | 0 | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Aberdeen Asset Management, Ltd. |
— | 44.12M | Annual Return |
BGF Investment Management, Ltd. |
— | 70.73M | Annual Return |
Dow (Gordon Lawrence Alan) |
— | 27.98M | Annual Return |
Freeman (Linda Margaret) |
— | 27.98M | Annual Return |
Getz Bros Co Ltd |
— | 134.06M | Annual Return |
Glenn (Jonathan) |
— | 1.32M | Annual Return |
Hargreaves Lansdown Asset Management Ltd. |
— | 52.98M | Annual Return |
John (C W N) |
— | 28.40M | Annual Return |
Marsh (David John) |
— | 31.56M | Annual Return |
Thalassa Holdings Ltd |
— | 214.48M | Annual Return |
Fundamentals
Market cap$3.96M
Enterprise value$4.75M
Revenue (TTM)$11.60M
Gross profit$3.05M
EBITDA$-502.00K
Net income$-895.00K
EPS (TTM)$-0.00
Free cash flow$491.75K
Total cash$813.00K
Total debt$1.60M
Book value / share$0.01
Shares outstanding932.82M
Float387.45M
Short % of float—
Dividend yield—
Beta (5Y)0.09
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.21
PEG ratio—
Price / sales—
Price / book53.13
EV / revenue0.41
EV / EBITDA-9.47
Gross margin26.31%
Operating margin-14.46%
Profit margin-7.71%
Return on equity-11.06%
Return on assets-3.81%
Debt / equity20.97
Current ratio1.48
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $11.60M | $11.95M | $12.01M | $11.34M | — | -2.9% |
| Operating revenue | $11.60M | $11.95M | $12.01M | $11.34M | — | -2.9% |
| Cost of revenue | $8.55M | $8.51M | $8.57M | $7.42M | — | +0.5% |
| Gross profit | $3.05M | $3.44M | $3.45M | $3.92M | — | -11.1% |
| Research & development | $1.26M | $1.15M | $1.10M | $1.16M | — | +9.9% |
| Selling, general & admin | $2.50M | $2.71M | $2.63M | $2.42M | — | -7.7% |
| Total operating expense | $3.93M | $4.07M | $4.04M | $3.85M | — | -3.5% |
| Operating income | -$878.00K | -$638.00K | -$588.00K | $73.00K | — | -37.6% |
| Net interest income | -$66.00K | -$99.00K | -$132.00K | -$98.00K | — | +33.3% |
| Pre-tax income | -$944.00K | -$2.05M | -$728.00K | -$57.00K | — | +54.0% |
| Tax provision | -$49.00K | -$107.00K | -$219.00K | -$321.00K | — | +54.2% |
| Net income | -$895.00K | -$1.94M | -$509.00K | $264.00K | — | +53.9% |
| Net income to common | -$895.00K | -$1.94M | -$509.00K | $264.00K | — | +53.9% |
| Basic EPS | -0.00 | — | -0.00 | 0.00 | -0.00 | — |
| Diluted EPS | -0.00 | — | -0.00 | 0.00 | -0.00 | — |
| EBIT | -$878.00K | -$1.95M | -$596.00K | $41.00K | — | +55.0% |
| EBITDA | -$220.00K | -$99.00K | $161.00K | $628.00K | — | -122.2% |
| Basic shares | 895.00M | 925.24K | 932.82M | 932.82M | — | +96,631.9% |
| Diluted shares | 895.00M | 925.24K | 933.67M | 935.95M | — | +96,631.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $813.00K | $195.00K | $1.21M | $2.20M | +316.9% |
| Cash & short-term investments | $813.00K | $195.00K | $1.21M | $2.20M | +316.9% |
| Accounts receivable | $1.63M | $1.75M | $1.58M | $1.76M | -6.7% |
| Inventory | $2.19M | $2.97M | $2.85M | $3.16M | -26.1% |
| Total current assets | $5.10M | $5.32M | $6.09M | $7.42M | -4.2% |
| Property, plant & equipment | $1.12M | $1.50M | $1.70M | $1.78M | -24.9% |
| Goodwill & intangibles | $5.42M | $5.42M | $6.53M | $6.40M | 0.0% |
| Total assets | $11.64M | $12.24M | $14.32M | $15.60M | -4.9% |
| Total current liabilities | $3.43M | $2.83M | $2.62M | $2.92M | +21.1% |
| Current debt | $150.00K | $352.00K | $352.00K | $382.00K | -57.4% |
| Long-term debt | $0 | $150.00K | $502.00K | $825.00K | -100.0% |
| Total debt | $665.00K | $1.24M | $1.66M | $2.16M | -46.4% |
| Total liabilities | $4.00M | $3.70M | $3.84M | $4.63M | +8.1% |
| Retained earnings | -$9.85M | -$8.95M | -$7.01M | -$6.53M | -10.0% |
| Shareholder equity | $7.65M | $8.54M | $10.48M | $10.96M | -10.5% |
| Working capital | $1.66M | $2.48M | $3.47M | $4.50M | -33.1% |
| Net tangible assets | $2.22M | $3.12M | $3.96M | $4.56M | -28.7% |
| Shares issued | 932.82M | 932.82M | 932.82M | 932.82M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$895.00K | -$1.94M | -$509.00K | $264.00K | +53.9% |
| Depreciation & amortisation | $658.00K | $1.85M | $757.00K | $587.00K | -64.5% |
| Stock-based compensation | $0 | $0 | $30.00K | $35.00K | — |
| Change in working capital | $809.00K | $35.00K | $43.00K | -$353.00K | +2,211.4% |
| Operating cash flow | $569.00K | -$74.00K | $400.00K | $486.00K | +868.9% |
| Capital expenditure | -$227.00K | -$335.00K | -$688.00K | -$1.08M | +32.2% |
| Investing cash flow | -$227.00K | -$335.00K | -$688.00K | -$1.08M | +32.2% |
| Financing cash flow | $271.00K | -$626.00K | -$672.00K | -$935.00K | +143.3% |
| Free cash flow | $342.00K | -$409.00K | -$288.00K | -$592.00K | +183.6% |
| End cash position | $813.00K | $195.00K | $1.21M | $2.20M | +316.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $813.00K | $195.00K | +316.9% |
| Cash & short-term investments | $813.00K | $195.00K | +316.9% |
| Accounts receivable | $1.63M | $1.75M | -6.7% |
| Inventory | $2.19M | $2.97M | -26.1% |
| Total current assets | $5.10M | $5.32M | -4.2% |
| Property, plant & equipment | $1.12M | $1.50M | -24.9% |
| Goodwill & intangibles | $5.42M | $5.42M | 0.0% |
| Total assets | $11.64M | $12.24M | -4.9% |
| Total current liabilities | $3.43M | $2.83M | +21.1% |
| Current debt | $150.00K | $352.00K | -57.4% |
| Long-term debt | $0 | $150.00K | -100.0% |
| Total debt | $665.00K | $1.24M | -46.4% |
| Total liabilities | $4.00M | $3.70M | +8.1% |
| Retained earnings | -$9.85M | -$8.95M | -10.0% |
| Shareholder equity | $7.65M | $8.54M | -10.5% |
| Working capital | $1.66M | $2.48M | -33.1% |
| Net tangible assets | $2.22M | $3.12M | -28.7% |
| Shares issued | 932.82M | 932.82M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | -0.00 | 1 | $12.39M | +6.8% |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target$1.40
High target$1.40
Low target$1.40
Implied upside229.41%
Analyst count1
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders53.97%
Held by institutions20.79%
Institutions holding5
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.43
-1.73% from price
SMA 20
0.47
-8.85% from price
SMA 50
0.48
-11.37% from price
SMA 100
0.47
-9.48% from price
SMA 200
0.48
-11.04% from price
EMA 12
0.44
-3.76% from price
EMA 26
0.46
-7.78% from price
EMA 50
0.47
-9.57% from price
RSI (14)
4.7
Oversold
MACD (12,26,9)
-0.02
Hist -0.01
ATR (14)
0.05
11.34% of price
Realised vol 30D
46.3%
Annualised
Bollinger upper
0.54
20, 2σ
Bollinger lower
0.39
20, 2σ
50 / 200 cross
Golden
0.48 vs 0.48
Trend bias
Below 200
-11.04%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.16
Less volatile than market
Correlation to SPY
-0.07
Largely independent
Realised vol 30D
46.3%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-39.3%
Peak to trough
Max drawdown 5Y
-86.0%
Peak to trough
ATR 14
0.05
11.34% of price
Beta (reported)
0.09
5Y monthly, from filing
Headlines
Net Asset Value(s)
Business Wire · 5m ago
AstraZeneca prices €2.55bn euro bond sale across four tranches
Proactive · 6m ago
Trees 'giving up': climate change hammers historic English gardens
AFP · 9m ago
Implantica to host Capital Markets Day in Stockholm on September 9
PR Newswire · 9m ago
Saudi Arabia to fund three new theme parks near Paris
Euronews · 10m ago
Cadeler: Q2 Earnings Snapshot
Associated Press · 11m ago
Solvonis raises £1.3m to fund three clinical programmes
Proactive · 11m ago
ZINZINO AB (PUBL.): INTERIM REPORT Q2 2026
PR Newswire · 12m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.